Related Experiment Video
Updated: Dec 1, 2025

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Plasma lipidomics of monozygotic twins discordant for multiple sclerosis
Horst Penkert1,2,3,4, Chris Lauber5, Mathias J Gerl5
1Department of Neurology, School of Medicine, Technical University of Munich (TUM), Munich, 81675, Germany.
Abstract:
Blood biomarkers of multiple sclerosis (MS) can provide a better understanding of pathophysiology and enable disease monitoring. Here, we performed quantitative shotgun lipidomics on the plasma of a unique cohort of 73 monozygotic twins discordant for MS. We analyzed 243 lipid species, evaluated lipid features such as fatty acyl chain length and number of acyl chain double bonds, and detected phospholipids that were significantly altered in the plasma of co-twins with MS compared to their non-affected siblings. Strikingly, changes were most prominent in ether phosphatidylethanolamines and ether phosphatidylcholines, suggesting a role for altered lipid signaling in the disease.

